My colleague Brittany Trang calculates that Vinay Prasad lasted fewer than eight Scaramuccis at the FDA — a Scaramucci is a ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.

Prasad’s departure may outline the political limits of medical skepticism in the Republican party, at least when it comes to ...

Moderna announced layoffs affecting 10% of its workforce amid government and competitive challenges to its vaccine business ...

Alnylam Pharmaceuticals’ new cardiovascular drug is off to a stronger-than-expected launch. The treatment, Amvuttra, brought ...

Facing a range of competitive and government challenges, Moderna announced layoffs Thursday affecting 10% of its workforce.

VC firm Frazier Life Sciences has raised a $1.3 billion fund, the firm’s largest to date and one of the few new biotech ...

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications ...

The immediate ebullient reaction to Vinay Prasad’s ouster is understandable, and may ultimately be the correct one, Adam ...

In many ways, despite what RFK Jr. and Rep. Paul Gosar claim, the Vaccine Injury Compensation Program is more friendly to ...

On this first week of clinical rotations as a medical student, my fears surrounding evaluation were nothing short of ...